Active Ingredient History

  • Now
Desvenlafaxine is a dual serotonin and norepinephrine reuptake inhibitor in vitro and in vivo that demonstrates good brain-to-plasma ratios. Desvenlafaxine has demonstrated antidepressant effects in preclinical studies. Pfizer is developing an oral, extended-release formulation of desvenlafaxine for the treatment of major depressive disorder. Desvenlafaxine has been registered and is available on the market for the treatment of major depressive disorder in adults.   NCATS

More Chemistry

Drug Pricing (per unit)

United States

$0.1317 - $13.6363


$0.2816 - $0.3458
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

desvenlafaxine | desvenlafaxine fumarate | desvenlafaxine succinate | dvs-233 | o-desmethylvenlafaxine | odv | pristiq | wy-45233


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue